Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial
Paton N.I.
Lancet Infectious Diseases
Q1Published: 2025Citations: 6
Abstract
Singapore National Medical Research Council; UK Department of Health and Social Care; UK Foreign, Commonwealth, and Development Office; UK Medical Research Council; Wellcome Trust; and UK Research and Innovation Medical Research Council.
Access to Document
10.1016/S1473-3099(25)00151-3Other files and links
- Link to publication in Scopus
- Open Access Version Available
Fingerprint
MedicineSciences
RifampicinSciences
Open labelSciences
TuberculosisSciences
Randomized controlled trialSciences
Pulmonary tuberculosisSciences
Internal medicineSciences
Stage (stratigraphy)Sciences
Physical therapySciences
SurgerySciences
PathologySciences
BiologySciences
PaleontologySciences